N-[2-[6-(2,4-difluorophenyl)-1-oxo-2,3-dihydroisoindol-5-yl]phenyl]-2-methyl-1,3-thiazole-5-sulfonamide
C24H17F2N3O3S2 — CID 171097829
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[6-(2,4-difluorophenyl)-1-oxo-2,3-dihydroisoindol-5-yl]phenyl]-2-methyl-1,3-thiazole-5-sulfonamide
N-[2-[6-(2,4-difluorophenyl)-1-oxo-2,3-dihydroisoindol-5-yl]phenyl]-2-methyl-1,3-thiazole-5-sulfonamide (PubChem CID 171097829) has the molecular formula C24H17F2N3O3S2 and a molecular weight of 497.55 g/mol. Its IUPAC name is N-[2-[6-(2,4-difluorophenyl)-1-oxo-2,3-dihydroisoindol-5-yl]phenyl]-2-methyl-1,3-thiazole-5-sulfonamide.
Molecular Properties
| Compound Name | N-[2-[6-(2,4-difluorophenyl)-1-oxo-2,3-dihydroisoindol-5-yl]phenyl]-2-methyl-1,3-thiazole-5-sulfonamide |
|---|---|
| PubChem CID | 171097829 |
| Molecular Formula | C24H17F2N3O3S2 |
| Molecular Weight | 497.55 g/mol |
| Exact Mass | 497.07 |
| IUPAC Name | N-[2-[6-(2,4-difluorophenyl)-1-oxo-2,3-dihydroisoindol-5-yl]phenyl]-2-methyl-1,3-thiazole-5-sulfonamide |
| SMILES | Cc1ncc(S(=O)(=O)Nc2ccccc2-c2cc3c(cc2-c2ccc(F)cc2F)C(=O)NC3)s1 |
| InChI | InChI=1S/C24H17F2N3O3S2/c1-13-27-12-23(33-13)34(31,32)29-22-5-3-2-4-17(22)19-8-14-11-28-24(30)18(14)10-20(19)16-7-6-15(25)9-21(16)26/h2-10,12,29H,11H2,1H3,(H,28,30) |
| InChIKey | QJHOQJGYNJAFMP-UHFFFAOYSA-N |
| XLogP | 5.11 |
| TPSA | 88.16 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 497.55 |
| LogP ≤ 5 | 5.11 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171097829 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.